{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:17:48Z","timestamp":1777904268901,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013111","name":"Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program","doi-asserted-by":"publisher","award":["TZ09B0046"],"award-info":[{"award-number":["TZ09B0046"]}],"id":[{"id":"10.13039\/501100013111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J1786"],"award-info":[{"award-number":["2023A04J1786"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008111","name":"Hainan Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["YSGZZ2024001"],"award-info":[{"award-number":["YSGZZ2024001"]}],"id":[{"id":"10.13039\/501100008111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172870"],"award-info":[{"award-number":["82172870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573549"],"award-info":[{"award-number":["82573549"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.medj.2025.100994","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:33:59Z","timestamp":1770996839000},"page":"100994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Cheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Qi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Xi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Yu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Fang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Bin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Long","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100994_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2020.08.019","article-title":"Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006-2016","volume":"151","author":"Xu","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib2","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/S0140-6736(24)00594-4","article-title":"Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial","volume":"403","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100994_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2025.1132","article-title":"Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial","volume":"333","author":"Liang","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100994_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0959-8049(00)00385-3","article-title":"Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer","volume":"37","author":"de Graeff","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.medj.2025.100994_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2019.09.008","article-title":"The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors","volume":"106","author":"So","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.medj.2025.100994_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2023.6552","article-title":"Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial","volume":"10","author":"Dai","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2025.01.014","article-title":"Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial","volume":"43","author":"Xu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2025.100994_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient Relat. Outcome Meas."},{"key":"10.1016\/j.medj.2025.100994_bib9","unstructured":"U.S. Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. (2019). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims."},{"key":"10.1016\/j.medj.2025.100994_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors","volume":"10","author":"McDowell","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.oraloncology.2015.10.020","article-title":"Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck","volume":"52","author":"Licitra","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.medj.2025.100994_bib13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jnci\/djac128","article-title":"Listening to the Patient Voice Adds Value to Cancer Clinical Trials","volume":"114","author":"Brundage","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.medj.2025.100994_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.2025.13205","article-title":"Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial","volume":"334","author":"Xu","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100994_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/cas.13250","article-title":"Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma","volume":"108","author":"Xu","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.medj.2025.100994_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104865","article-title":"Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants","volume":"109","author":"McDowell","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib18","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.6004\/jnccn.2020.0012","article-title":"NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020","volume":"18","author":"Thompson","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.medj.2025.100994_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gregoire","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cac2.12218","article-title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma","volume":"41","author":"Tang","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.medj.2025.100994_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.medj.2025.100994_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","article-title":"Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35","volume":"17","author":"Bjordal","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib25","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S","article-title":"The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity","volume":"77","author":"List","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.medj.2025.100994_bib26","series-title":"The EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.medj.2025.100994_bib27","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1200\/JCO.22.02776","article-title":"Interpreting the Significance of Changes in Health-Related Quality-of-Life Scores","volume":"41","author":"Osoba","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100994_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.22799","article-title":"Interpreting clinically significant changes in patient-reported outcomes","volume":"110","author":"Ringash","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.medj.2025.100994_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0163278705275340","article-title":"Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience","volume":"28","author":"Yost","year":"2005","journal-title":"Eval. Health Prof."},{"key":"10.1016\/j.medj.2025.100994_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/000711001159357","article-title":"The analysis of repeated measures designs: a review","volume":"54","author":"Keselman","year":"2001","journal-title":"Br. J. Math. Stat. Psychol."},{"key":"10.1016\/j.medj.2025.100994_bib31","article-title":"Multiple hypothesis testing and Bonferroni's correction","volume":"349","author":"Sedgwick","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.medj.2025.100994_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2529620","article-title":"Covariance analysis of censored survival data","volume":"30","author":"Breslow","year":"1974","journal-title":"Biometrics"},{"key":"10.1016\/j.medj.2025.100994_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0140-6736(02)08594-X","article-title":"Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls","volume":"359","author":"Pocock","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100994_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model","volume":"39","author":"Schoenfeld","year":"1983","journal-title":"Biometrics"},{"key":"10.1016\/j.medj.2025.100994_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(17)30421-7","article-title":"Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial","volume":"18","author":"Harrington","year":"2017","journal-title":"Lancet Oncol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025004210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025004210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:20:09Z","timestamp":1777638009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025004210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666634025004210"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100994","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100994"}}